Skip Navigation

U.S. Department of Health & Human Services
Navigation to Home, Contact Us, Site Map, About REMM
Radiation Event Medical Management (REMM)
REMM Banner
Search REMM Web Site
What Kind of Emergency? Initial Event Activities Patient Management Algorithms Management Modifiers Tools & Guidelines

REMM Home Contact Us Site Map About REMM
 

You are here: Home > Managing Internal Contamination > Sodium Alginate


 
  Features
  Quick Links
  Other Web Resources
 

Sodium Alginate



Indications and Usage


  • A derivative of kelp used in the manufacture of ice cream.
  • Oral alginates efficiently bind strontium in the gastrointestinal tract and prevent its absorption.
  • The dose is 10 gm powder in a 30 cc vial; add water and drink.

FDA Product Safety Info

  • Not FDA approved for this indication/off-label use
  • Practical use of sodium alginate may be limited by viscosity and limited commercial availability.

top of page



References

  1. Marcus, CS. Administration of decorporation drugs to treat internal radionuclide contamination: medical emergency response to radiologic incidents. RSO Magazine, 2004;9(5):9-15. (PDF - 34 KB)
  2. "Radiation Bioterrorism," Tochner ZA, Lehavi O, Glatstein E, Chapter 207 in Harrison's Principles of Internal Medicine, Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, eds. 16th Edition, pp 1294-1300, McGraw-Hill, 2005
  3. Management of Persons Accidentally Contaminated with Radionuclides, National Council on Radiation Protection and Measurements, NCRP Report No. 65, Bethesda, MD, 1980.
 

US Department of Health & Human Services     
U.S. Department of Health & Human Services Office of the Assistant Secretary for Preparedness and Response National Library of Medicine